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Background
HIV vaccine design has focused on epitopes seen by
broadly neutralizing antibodies (bNAbs). The key to devel-
oping a robust vaccine capable of eliciting bNAbs is to
identify the epitopes appropriate for incorporation into
vaccines and to exclude irrelevant or harmful epitopes.
Methods
To assess bNAb B cell responses, we have developed
series of bNAb B cell lines and b12 ‘knock-in’ mouse.
Results
Antibodies targeting the CD4 binding site, including
PGV04 and b12, expressed higher levels of surface Ig
compared to MPER targeting antibody 4E10. Correlating
with the cell line data, in b12 heavy chain knock-in mice,
B cells could develop robustly (this was not the case in
4E10 mice). 10-20% of b12 transgenic B cells bound to
YU2 gp120 monomer and lacked expression of CD93,
indicating that they matured normally and were non-
anergic. Upon immunization with YU2 trimer, b12 mice
exhibited strong gp120-specific IgG responses. Gp120-
binding cells used Vk10-96 and Vk19-93, but were
skewed to usage of Jk2 and Jk4, which are normally used
less frequently than Jk1 and Jk5. Cells in the gp120- non
binding fraction frequently expressed Vk1-135. Interest-
ingly, the CDR1 length of Vk1-135 is 11 amino acids in
length, whereas in Vk10-96 and Vk19-93 genes it is 6
amino acids, suggesting that a short CDR1 is important
for gp120 binding. Several anti-gp120 hybridomas were
established from LPS-stimulated B cells. However, com-
pared to the original b12 antibody, these hybridoma cells
did not show strong neutralization activity.
Conclusion
The antibodies targeting CD4 binding site are appar-
ently not autoreactive, supporting the notion that this is
a desirable epitope for vaccine target. B12 H chain
knock in mouse data showed light chain is important
for bNAb function. B12 knock in mice and recently gen-
erated b12 germline strains are suitable for vaccine
study.
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